China Universal Asset Management Company’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $364K | Buy |
11,533
+30
| +0.3% | +$948 | 0.03% | 269 |
|
|
2025
Q1 | $382K | Sell |
11,503
-590
| -5% | -$19.6K | 0.04% | 266 |
|
|
2024
Q4 | $416K | Buy |
12,093
+1,162
| +11% | +$40K | 0.04% | 267 |
|
|
2024
Q3 | $437K | Buy |
10,931
+4,259
| +64% | +$170K | 0.05% | 237 |
|
|
2024
Q2 | $201K | Sell |
6,672
-4,221
| -39% | -$127K | 0.03% | 244 |
|
|
2024
Q1 | $366K | Buy |
10,893
+4,116
| +61% | +$138K | 0.05% | 213 |
|
|
2023
Q4 | $219K | Buy |
6,777
+5,244
| +342% | +$169K | 0.04% | 197 |
|
|
2023
Q3 | $50.2K | Buy |
1,533
+748
| +95% | +$24.5K | 0.01% | 232 |
|
|
2023
Q2 | $27.6K | Sell |
785
-22
| -3% | -$774 | 0.01% | 240 |
|
|
2023
Q1 | $26.3K | Buy |
807
+204
| +34% | +$6.66K | 0.01% | 195 |
|
|
2022
Q4 | $33.2K | Buy |
603
+49
| +9% | +$2.7K | 0.01% | 152 |
|
|
2022
Q3 | $25K | Buy |
+554
| New | +$25K | 0.01% | 144 |
|